Before it took over her life, Leila Gharani mostly took Microsoft Excel for granted. She was working on a process optimization project for a large paper-products manufacturer—a job that, to hear her ...

Grizzly bear attacks elementary school children on class walk Nearly 800 air traffic controllers and techs with perfect attendance during shutdown to receive $10K bonuses Kelsie Whitmore makes history ...

AT&T's $177 million settlement is for data breaches in 2019 and 2024. Claim up to $5,000 (first breach) and $2,500 (Snowflake hack), or both. File claim by Dec. 18, 2025, either online or by mail. If ...

pandas is the (avocado) toast of Python data analysis. Here are the reasons why.

DEXTER, Maine (WABI) - The Dexter Tigers won $75,000 in the T-Mobile Friday Night 5G Lights online vote contest for football facility upgrades. First, the Tigers made the top 25 for $25,000. Then, ...

Bell County Commissioners Louie Minor, D-Killeen, and Bobby Whitson, R-Harker Heights, presented a $3 million check for the design and construction of the Chaparral Road project to Killeen City ...

ARS Pharma to showcase a late-breaking oral presentation and six poster presentations highlighting real world impact of neffy® (epinephrine nasal spray) Oral presentation to report results from real ...

A massive leak has exposed more than 183 million email passwords, including tens of millions linked to Gmail accounts, in what cybersecurity analysts are calling one of the biggest credential dumps ...

DUBLIN and CHICAGO, Oct. 14, 2025 (GLOBE NEWSWIRE) -- Iterum Therapeutics plc (Nasdaq: ITRM) (the Company), a company focused on delivering next generation oral and IV antibiotics to treat infections ...

ZUG, Switzerland and BOSTON, Oct. 01, 2025 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for serious ...

LONDON, Oct. 01, 2025 (GLOBE NEWSWIRE) -- Spur Therapeutics today announced it will present new clinical data for avigbagene parvec (FLT201), its Phase 3-ready gene therapy candidate for Gaucher ...